Preparation method of fulvestrant intermediate
By using low-temperature reaction catalyzed by magnesium chips and cuprous chloride in fulvestrant synthesis, combined with high-performance liquid chromatography detection, the problem of difficult removal of 7β isomer impurities in Mike addition reaction was solved, and fulvest was improved The purity and yield of group intermediates are suitable for industrial production.
Patent Information
- Application Number
- CN202310534109.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-12
- Publication Date
- 2024-11-12
AI Technical Summary
In the existing fulvestrant synthesis method, the introduction of side chain reaction of Mike addition results in difficult removal of 7β isomer impurities, affecting product purity and yield, and industrial production is not suitable.
By adding magnesium chips to tetrahydrofuran, nitrogen protection is introduced, heated to reflux and added 9-bromonoxy tert-butyldimethylsilane, followed by reaction with 6-dehydronorone acetate and Grignard reagent at low temperature , the reaction was catalysis, and the reaction was terminated and extracted and washed, and high performance liquid chromatography was used to control the ratio of 7α:7β.
The purity and yield of 7α products have been improved, the ratio of 7α:7β reaches 12:1, and the impurity 7β content is reduced to 7.5%, making it suitable for industrial production.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The present invention relates to a method for preparing a fulvestrant intermediate. Background Art
[0002] Fulvestrant, chemically named (7α, 17β)-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-estra-1,3,5(10)-triene-3,17-diol, has the following structural formula:
[0003] Fulvestrant is a new anti-breast cancer drug developed by Astrazeneca. It was first launched in the United States in 2002 and approved for marketing by the European Union in 2004.
[0004] There are two main routes for the synthesis of Fulvestrant: the first is a method for synthesizing Fulvestrant and similar structural compounds disclosed in US4659516. This route starts with 6-dehydronandrolone acetate and obtains the finished product Fulvestrant through 10 steps of reaction, with a total molar yield of less than 10%. The synthetic route is as follows:
[0005] There is a very important fulvestrant intermediate in this route, (7α,17β)-7-{9-[(tert-butyldimethylsilyl)oxy]nonyl}estra-1,3,5(10)-triene-3,17-diol-17-acetate (Compound III), whose structural formula is as follows:
[0006] It is obtained by Michael addition of 6-dehydronandrolone acetate and Grignard reagent. However, due to the stereoselectivity problem of this reaction, the product after the 7-position addition will inevitably produce chiral isomer impurities, of which the 7α configuration is the desired product compound III, and the 7β configuration is the 7-position chiral isomer. The ratio of 7α:7β in the obtained product is 2.5:1. In addition, US Patent US2006030552 describes a similar method, in which the ratio of the product 7α:7β obtained by Michael addition can be increased to 8:1, which greatly increases the possibility of industrialization of this route and becomes the main route for the current synthesis of Fulvestrant.
[0007] The second route is a method disclosed in WO2009039700, which uses estradiol as the starting material, introduces a side chain by nucleophilic substitution, and can also produce fulvestrant through 6 steps of reaction. However, this route has many disadvantages, such as the use of ultra-low temperature (-78°C) reactions in multiple steps and the use of column chromatography purification multiple times, resulting in a very low yield. Even after continuous optimization, this route is still not suitable for large-scale production.
[0008] On the whole, the route of introducing side chains by Michael addition is currently the most promising route for industrialization. It must be pointed out that the Michael addition reaction not only directly affects the product yield, but also affects the quality of the final product, Fulvestrant, and is an extremely critical step in this route. Even if we obtain compound III with 7α:7β=8:1, since the polarity between the desired product and the isomer is very close, the 7β isomer must be separated and removed by silica gel column chromatography, and it is also very difficult to reduce the percentage content of the 7β isomer to below 0.5%. Both the United States Pharmacopoeia USP40-NF35 and the European Pharmacopoeia EP9.0 have drug standards for Fulvestrant. Among them, the related substances of Fulvestrant in the European Pharmacopoeia EP9.0 involve related substance A, and the structure is as follows:
[0009] The related substances of Fulvestrant in the United States Pharmacopoeia USP40-NF35 include related substance 6 as follows:
[0010] These two impurities are the same substance, and their source is the isomeric impurity produced by the addition of Michael to the 7-position, with the following structure:
[0011] Of course, there are many options for the side chain used to connect to the parent ring, but they all become the same impurity after being derived to Fulvestrant. No matter how the side chain changes, the generation of the corresponding 7β impurity during Michael addition is inevitable. The 7β isomer has similar properties to the desired product 7α and will continue to be derived into the final product Fulvestrant. Therefore, it is necessary to optimize the reaction of introducing the side chain using Michael addition and control the generation of the 7β impurity in the reaction to improve the purity and yield of the desired 7α product. Summary of the invention
[0012] In order to solve the above problems, the present invention provides a method for preparing a fulvestrant intermediate.
[0013] The preparation method of the present invention can be represented by the following reaction formula:
[0014] The technical solution of the present invention mainly comprises the following steps: Step (1): Add tetrahydrofuran and magnesium chips to the reactor, introduce nitrogen protection, heat to reflux, keep the jacket at a constant temperature of 65°C, add 5% of the total amount of 9-bromononyloxy tert-butyldimethylsilane (Compound I) to the reactor, and reflux until the reaction is initiated. Then, drip the remaining 95% of Compound I within a certain period of time, and the temperature of the reaction solution continues to rise during the dripping process. After the compound I is dripped, the temperature reaches 85°C, and the jacket is heated to 85°C and refluxed for 1 hour. After ensuring that the compound I is completely reacted by TLC, the reaction solution is cooled to 45°C to prepare for the next step. Step (2): In another reactor, mix tetrahydrofuran and 6-dehydronandrolone acetate (Compound II), add cuprous chloride under rapid stirring, cool to between -25°C and -30°C, drip the Grignard reagent prepared in step (1) within a certain period of time, and control the temperature of the reaction solution between -20°C and -30°C. After the Grignard reagent is dripped, keep the reaction warm for 30 minutes. Add glacial acetic acid to terminate the reaction, and react at 0-10°C for 30 minutes. Then add n-heptane and saturated brine to extract, and wash away cuprous chloride with ammonia water and saturated brine. The upper oil layer is washed with saturated brine, dried with anhydrous sodium sulfate, and concentrated under reduced pressure at 55-60°C to obtain a product containing compound III. HPLC detection shows that the purity of compound III is 90.3%, impurity 7β is 7.5%, and the ratio of 7α:7β is 12:1.
[0015] In step (1), compound I needs to be purified (fast column chromatography), and a purity of >97% is conducive to the control of reaction impurities.
[0016] The magnesium chips used in step (1) have a particle size of 10-20 mesh, which can enable the reaction to be initiated quickly and fully.
[0017] The reaction solvent in step (1) is preferably tetrahydrofuran. Since the boiling point of methyltetrahydrofuran is significantly higher than that of tetrahydrofuran, it is easy to cause a violent Grignard reaction and violent boiling.
[0018] The tetrahydrofuran in step (1) is anhydrous tetrahydrofuran, and the water content is less than 50 ppm.
[0019] In step (1), the reflux temperature is 65-85°C, and the jacket is kept heated at at least 65°C to control the reflux rate. The appropriate temperature can make the compound I and the magnesium chips react fully, and will not cause the Grignard reaction to rush due to the accumulation of reaction heat.
[0020] In step (1), an appropriate amount of compound I needs to be added to initiate the reaction. When the reaction is initiated, the reaction liquid changes from light yellow to gray-black, and the surface of the magnesium chips changes from shiny to dull. If the reaction is successfully initiated, the temperature inside the reaction liquid rises from a constant 65°C to 67°C, which is significantly higher than the jacket set temperature of 65°C.
[0021] The time for adding compound I in step (1) is 3-4 hours to ensure that the reaction solution continues to reflux smoothly. If the adding time is too long, it is easy to cause polymerization of the Grignard reagent, and if it is too short, it is easy to cause material rushing.
[0022] In step (1), the TLC detection uses n-heptane as the developing solvent, GF254 silica gel plate as the spotting plate, and an iodine cylinder as the color developing agent.
[0023] After the preparation of the Grignard reagent in step (1) is completed, it should be kept warm at 40-45°C. If the temperature is lower than 40°C, the Grignard reagent is likely to precipitate solids, which is not conducive to the next step of dropwise addition; if the temperature is higher than 45°C, it is not conducive to the temperature control of the next step of low-temperature reaction.
[0024] In step (2), the reaction solvent is preferably tetrahydrofuran, and the use of mixed solvents should be avoided.
[0025] In step (2), the catalyst is preferably cuprous chloride, and it is necessary to ensure that the cuprous chloride is freshly made (off-white). If the cuprous chloride is oxidized, it will turn yellow-green. The best effect is achieved when the amount of cuprous chloride is 5% of 6-dehydronandrolone acetate. Cuprous chloride and cuprous bromide have similar catalytic effects, and cuprous chloride has low cost, so cuprous chloride is preferred. In addition, cuprous chloride is insoluble in tetrahydrofuran, and a relatively fast stirring speed is required to keep the reaction solution uniform.
[0026] The reaction temperature in step (2) is preferably -20°C to -30°C. If the reaction temperature is too low, such as below -40°C, the reaction will be slow, which will not only increase energy consumption, but also cause the excess unreacted Grignard reagent to aggregate, which will also cause the proportion of 7β impurity to increase slightly. If the reaction temperature is too high, such as rising to -10°C, the Grignard reagent will be dealkylated, which will also cause a significant increase in the content of 7β impurity (7β impurity>10%).
[0027] In step (2), the Grignard reagent should be added dropwise at a constant speed, preferably within 5-6 hours, to allow the reaction to proceed fully. If the Grignard reagent is added dropwise too quickly, the 7β impurity will increase significantly.
[0028] In step (2), the TLC developing solvent is a mixture of 20% ethyl acetate and 80% n-heptane, the plate is spotted on a GF254 silica gel plate, and the color is developed using an ultraviolet lamp at 254 nm.
[0029] In step (2), anhydrous glacial acetic acid is used to terminate the reaction. If an acid containing water, such as hydrochloric acid, is added, the excess Grignard reagent reacts with water to produce a large amount of floccules, which will make it difficult to separate the subsequent product layer and the water layer.
[0030] The extraction solvent used in step (2) is n-heptane. Since the reaction solvent is tetrahydrofuran, which is highly water-soluble, an organic solvent with low polarity and low water solubility is selected to avoid loss of product yield. Petroleum ether, n-hexane, and n-heptane can all be used, with n-heptane being preferred.
[0031] In step (2), ammonia water is used to wash away cuprous chloride in the system. Ammonia water chelates with cuprous ions to make the reaction solution blue. Washing until the reaction solution is colorless ensures that copper ions are not carried into the next step.
[0032] The conventional detection method for the product obtained in step (2) is high performance liquid chromatography. Since compound I is in excess relative to 6-dehydronandrolone acetate, compound I is derived into silane impurities after Grignard reaction and post-treatment, which will cause the weight yield of the product to exceed the theoretical yield. These silane impurities have no ultraviolet absorption and cannot be detected by HPLC. They will not affect the ratio of 7α and 7β in the product, and can be completely removed by subsequent column chromatography, and will not affect the yield of the product after column chromatography. Specific implementation plan
[0033] Example 1: Preparation of Compound III Add 30L tetrahydrofuran and 0.94kg magnesium powder (39.2mol) to a 100L reactor, pass nitrogen protection, and heat to 65℃ under stirring. Add 475g 9-bromononyloxy tert-butyldimethylsilane (1.4mol), reflux to initiate the reaction, slowly drop 9.02kg 9-bromononyloxy tert-butyldimethylsilane (26.8mol), keep reflux, drop in 3.5 hours, then heat to 85℃ and continue to reflux for 1 hour, cool to 45℃, and stand by. Add 50L tetrahydrofuran and 7kg 6-dehydronandrolone acetate (22.3mol) to a 200L reactor, add 0.35kg cuprous chloride under rapid stirring, cool to -25℃, drop the prepared Grignard reagent, and control the internal temperature between -20℃ and -25℃. The addition was completed in 5.5 hours, and the reaction was continued for 30 minutes. TLC detection showed that the compound II spot disappeared in the reaction solution. Stop the reaction, add 18KG glacial acetic acid, and react at 0-10℃ for 30 minutes. Then add 40L n-heptane and 60kg saturated brine for extraction. The upper oil layer is washed twice with 60kg saturated brine and 5kg 25% ammonia water respectively, and finally washed once with 60kg saturated brine. After washing, the upper oil is dried with anhydrous sodium sulfate and concentrated under reduced pressure at 55-60℃. A light yellow oil is obtained, 17.4KG. The product purity is detected as 7α (compound III): 90.5%, 7β: 7.4%, and the ratio of 7α: 7β = 12.2: 1.
[0034] Example 2: Preparation of Compound III Add 30L tetrahydrofuran and 0.94kg magnesium powder (39.2mol) to a 100L reactor, pass nitrogen protection, and heat to 65℃ under stirring. Add 475g 9-bromononyloxy tert-butyldimethylsilane (1.4mol), reflux to initiate the reaction, slowly drop 9.02kg 9-bromononyloxy tert-butyldimethylsilane (26.8mol), keep reflux, drop in 3.3 hours, then heat to 85℃ and continue reflux for 1 hour, cool to 45℃, and stand by. Add 50L tetrahydrofuran and 7kg 6-dehydronandrolone acetate (22.3mol) to a 200L reactor, add 0.4kg cuprous bromide under rapid stirring, cool to -25℃, drop the prepared Grignard reagent, and control the internal temperature between -20℃ and -25℃. The addition was completed in 5.2 hours, and the reaction was continued for 30 minutes. TLC detection showed that the compound II spot disappeared in the reaction solution. Stop the reaction, add 18KG glacial acetic acid, and react at 0-10℃ for 30 minutes. Then add 40L n-heptane and 60kg saturated brine for extraction. The upper oil layer is washed twice with 60kg saturated brine and 5kg 25% ammonia water, and finally washed once with 60kg saturated brine. After washing, the upper oil is dried with anhydrous sodium sulfate and concentrated under reduced pressure at 55-60℃. A light yellow oil is obtained, 17.7KG. The product purity is detected as 7α (compound III): 90.6%, 7β: 7.5%, and the ratio of 7α: 7β = 12.1: 1.
Claims
1. A method for preparing a fulvestrant intermediate, characterized in that: The following steps are involved: Step (1) Add magnesium chips to solvent A and heat to reflux. Weigh compound I, first add 5% of compound I to initiate the reaction, then dropwise add the remaining 95%, and react compound I with magnesium chips to prepare a Grignard reagent. Step (2) In another reaction kettle, first mix compound II and the catalyst with solvent A. Dropwise add the prepared Grignard reagent. Control the optimal dropping temperature and dropping time, continue the reaction until the Grignard reagent is finished, quench with acid, then extract the product with solvent B, wash the organic layer with ammonia water to remove the catalyst, and concentrate under reduced pressure to obtain a mixture containing the fulvestrant intermediate compound III.
2. The preparation method according to claim 1, wherein the solvent A in step (1) is tetrahydrofuran or methyltetrahydrofuran.
3. According to the preparation method of claim 1, the temperature range of the reflux reaction in step (1) is 65-85°C, and the reflux time is 3-4 hours.
4. According to the preparation method according to claim 1, the molar ratio of the magnesium chips to compound I in step (1) is 1.3-1.7:
1.
5. The preparation method according to claim 1, wherein the catalyst in step (2) is one of cuprous chloride, cuprous bromide and cuprous iodide, and the molar amount thereof is 1% to 2% of compound II.
6. The preparation method according to claim 1, wherein the solvent A in step (2) is tetrahydrofuran or methyltetrahydrofuran, and the solvent B is n-heptane or n-hexane.
7. The preparation method according to claim 1, wherein the molar ratio of the Grignard reagent to compound II in step (2) is 1.2-1.5:
1.
8. The preparation method according to claim 1, wherein the optimal dropping temperature in step (2) is controlled to be in the range of -30°C to -20°C, and the optimal dropping time is in the range of 5-6 hours.
